FC
EW icon

FORA Capital’s Edwards Lifesciences EW Stock Holding History

FORA Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-87,974
Closed -$5.81M – 448
2024
Q3 		$5.81M Buy
+87,974
New +$6.39M 0.68% 39
2024
Q1 		– Sell
-34,582
Closed -$2.64M – 453
2023
Q4 		$2.64M Sell
34,582
-40,642
-54% -$2.83M 0.23% 126
2023
Q3 		$5.21M Buy
+75,224
New +$6.05M 0.46% 58
2023
Q1 		– Sell
-50,109
Closed -$3.74M – 572
2022
Q4 		$3.74M Buy
50,109
+27,178
+119% +$2.09M 0.6% 37
2022
Q3 		$1.9M Buy
22,931
+9,661
+73% +$930K 0.36% 75
2022
Q2 		$1.26M Buy
+13,270
New +$1.37M 0.25% 127
2020
Q4 		– Sell
-2,057
Closed -$164K – 982
2020
Q3 		$164K Buy
+2,057
New +$161K 0.11% 207

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

FORA Capital's EW Position: Q4 2024 in Review

FORA Capital sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 87,974 shares — an estimated $5.81M sold.

FORA Capital first reported a position in EW in Q3 2020 and held it in 7 quarters. The position peaked at $5.81M in Q3 2024. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • FORA Capital reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • FORA Capital sold 87,974 Edwards Lifesciences shares in Q4 2024, an estimated $5.81M.
  • FORA Capital first reported a position in Edwards Lifesciences in Q3 2020 and held it in 7 quarters.
  • FORA Capital's Edwards Lifesciences position peaked at $5.81M in Q3 2024.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on FORA Capital's 13F filing for Q4 2024, filed 14 Feb 2025.